(Q33488907)
Statements
Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer (English)
R S de Jong
P H Willemse
H Boonstra
W T van der Graaf
D T Sleijfer
A G van der Zee